| dc.contributor.author | Euler, Gerhild | |
| dc.date.accessioned | 2022-11-18T09:51:00Z | |
| dc.date.available | 2016-02-25T12:57:52Z | |
| dc.date.available | 2022-11-18T09:51:00Z | |
| dc.date.issued | 2015 | |
| dc.identifier.uri | http://nbn-resolving.de/urn:nbn:de:hebis:26-opus-119696 | |
| dc.identifier.uri | https://jlupub.ub.uni-giessen.de//handle/jlupub/9172 | |
| dc.identifier.uri | http://dx.doi.org/10.22029/jlupub-8560 | |
| dc.description.abstract | Myocardial infarction is a prevailing cause of death in industrial countries. In spite of the good opportunities we have nowadays in interventional cardiology to reopen the clotted coronary arteries for reperfusion of ischemic areas, post-infarct remodeling emerges and contributes to unfavorable structural conversion processes in the myocardium, finally resulting in heart failure. The growth factor TGFß is upregulated during these processes. In this review, an overview on the functional role of TGFß signaling in the process of cardiac remodeling is given, as it can influence apoptosis, fibrosis and hypertrophy thereby predominantly aggravating ischemia/reperfusion injury. | en |
| dc.language.iso | en | de_DE |
| dc.rights | Namensnennung 3.0 International | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/3.0/ | * |
| dc.subject | myocardial infarction | en |
| dc.subject | transforming growth factor beta | en |
| dc.subject | SMAD | en |
| dc.subject | microRNA | en |
| dc.subject | hypertrophy | en |
| dc.subject.ddc | ddc:610 | de_DE |
| dc.title | Good and bad sides of TGFbeta-signaling in myocardial infarction | en |
| dc.type | article | de_DE |
| local.affiliation | FB 11 - Medizin | de_DE |
| local.opus.id | 11969 | |
| local.opus.institute | Institute of Physiology | de_DE |
| local.opus.fachgebiet | Medizin | de_DE |
| local.source.uri | https://doi.org/10.3389/fphys.2015.00006 | |
| local.source.freetext | Frontiers in Physiology 6:66 | de_DE |
